(AOF) – Implanet announces a turnover of 1.53 million euros in the third quarter, down 17% year-on-year. The medical technology company specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment specifies that it achieved a turnover of 5.81 million euros over the first nine months of 2023, to compare to the 5.97 million euros achieved over the same period in 2022.
As of September 30, 2023, the company had cash of 0.43 million euros, insufficient “in view of the company’s current operational development plan to finance the activity over the next twelve months”.
The company’s Board of Directors, in its meeting of October 9, 2023, therefore authorized the establishment of short-term financing of a maximum amount of 1.3 million euros in nominal value in dry bonds with of two non-shareholder investors of the company.
Implanet specifies that “based on current cash flow forecasts and in the absence of obtaining new sources of financing, the drawing of the first tranche allows the company to be financed until December 31, 2023”.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
